Related Experiment Videos
P53: a determinant of the cell cycle response to DNA damage
1Johns Hopkins Oncology Center, Baltimore, Md. 21287.
Advances in Experimental Medicine and Biology
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cellular survival pathways and resistance to cancer therapy.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2006
The ATM-dependent DNA damage signaling pathway.
Cold Spring Harbor symposia on quantitative biology·2006
ATM--a key determinant of multiple cellular responses to irradiation.
Acta oncologica (Stockholm, Sweden)·2002
ATM: genome stability, neuronal development, and cancer cross paths.
Advances in cancer research·2001
Nucleoskeletal Proteins in Early Embryogenesis.
Advances in experimental medicine and biology·2026
Nuclear Dynamics and Its Timing Regulation Revealed by Live-Cell Imaging.
Advances in experimental medicine and biology·2026
Histone Modifications in Mammalian Early Embryos.
Advances in experimental medicine and biology·2026
Oocyte Kinetochores at the Nexus of Meiotic Drive and Segregation Fidelity.
Advances in experimental medicine and biology·2026
Asymmetric Chromosome Establishment and Segregation During Germline Stem Cell Division.
Advances in experimental medicine and biology·2026
Non-random Sister Chromatid Segregation Mediated by Ribosomal DNA in Drosophila Male Germline Stem Cells.
Advances in experimental medicine and biology·2026
A marine-derived meroterpenoid inhibits colorectal cancer via PI3K pathway modulation in mice.
Marine life science & technology·2026
SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.
Journal of molecular and cellular cardiology plus·2026